p-inulin
Small moleculeexperimental
Clinical trial activity
4 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2015 (NCT02572882)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- p-inulin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04836637 | N/A | May 17, 2021 | University of Copenhagen |
| NCT03348592 | N/A | Oct 31, 2016 | Department of Veteran Affairs, George Washington University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The Cleveland Clinic, University of Pennsylvania |
| NCT03265639 | Phase 1 | Apr 21, 2016 | George Washington University |
| NCT02572882 | Phase 1 | Oct 1, 2015 | George Washington University, Harvard University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Pennsylvania, University of Washington, Vanderbilt University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| George Washington University | Academic/Hospital | 3 | 1 | 2 | 2015 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 2 | 1 | 2 | 2015 |
| University of Pennsylvania | Academic/Hospital | 2 | 1 | 2 | 2015 |
| Department of Veteran Affairs | Government | 1 | 0 | 1 | 2016 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| The Cleveland Clinic | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2015 |
9 organizations
Page 1 / 1